Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure

被引：40

作者：

Jaye, MC ^{[1
]}

Krawiec, JA ^{[1
]}

Campobasso, N ^{[1
]}

Smallwood, A ^{[1
]}

Qiu, CY ^{[1
]}

Lu, Q ^{[1
]}

Kerrigan, JJ ^{[1
]}

Alvaro, MDL ^{[1
]}

Laffitte, B ^{[1
]}

Liu, WS ^{[1
]}

Marino, JP ^{[1
]}

Meyer, CR ^{[1
]}

Nichols, JA ^{[1
]}

Parks, DJ ^{[1
]}

Perez, P ^{[1
]}

Sarov-Blat, L ^{[1
]}

Seepersaud, SD ^{[1
]}

Steplewski, KM ^{[1
]}

Thompson, SK ^{[1
]}

Wang, P ^{[1
]}

Watson, MA ^{[1
]}

Webb, CL ^{[1
]}

Haigh, D ^{[1
]}

Caravella, JA ^{[1
]}

Macphee, CH ^{[1
]}

Willson, TM ^{[1
]}

Collins, JL ^{[1
]}

机构：

[1] GlaxoSmithKline Res & Dev Ltd, Res Triangle Pk, NC 27709 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2005年 / 48卷 / 17期

关键词：

D O I：

10.1021/jm050532w

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Substituted 3-(phenylamino)-1H-pyrrole-2,5-diones were identified from a high throughput screen as inducers of human ATP binding cassette transporter A1 expression. Mechanism of action studies led to the identification of GSK3987 (4) as an LXR ligand. 4 recruits the steroid receptor coactivator-1 to human LXR alpha and LXRP with EC(50)s of 40 nM, profiles as an LXR agonist in functional assays, and activates LXR though a mechanism that is similar to first generation LXR agonists.

引用

页码：5419 / 5422

页数：4

共 28 条

[11]

Jaye Michael, 2003, Curr Opin Investig Drugs, V4, P1053

[12] Reciprocal regulation of inflammation and lipid metabolism by liver X receptors [J].

Joseph, SB ;

Castrillo, A ;

Laffitte, BA ;

Mangelsdorf, DJ ;

Tontonoz, P .

NATURE MEDICINE, 2003, 9 (02) :213-219

[13] Synthetic LXR ligand inhibits the development of atherosclerosis in mice [J].

Joseph, SB ;

McKilligin, E ;

Pei, LM ;

Watson, MA ;

Collins, AR ;

Laffitte, BA ;

Chen, MY ;

Noh, G ;

Goodman, J ;

Hagger, GN ;

Tran, J ;

Tippin, TK ;

Wang, XP ;

Lusis, AJ ;

Hsueh, WA ;

Law, RE ;

Collins, JL ;

Willson, TM ;

Tontonoz, P .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (11) :7604-7609

[14] Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue [J].

Laffitte, BA ;

Chao, LC ;

Li, J ;

Walczak, R ;

Hummasti, S ;

Joseph, SB ;

Castrillo, A ;

Wilpitz, DC ;

Mangelsdorf, DJ ;

Collins, JL ;

Saez, E ;

Tontonoz, P .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (09) :5419-5424

[15] Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway [J].

Lehmann, JM ;

Kliewer, SA ;

Moore, LB ;

SmithOliver, TA ;

Oliver, BB ;

Su, JL ;

Sundseth, SS ;

Winegar, DA ;

Blanchard, DE ;

Spencer, TA ;

Willson, TM .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (06) :3137-3140

[16] The SRC family of nuclear receptor coactivators [J].

Leo, C ;

Chen, JD .

GENE, 2000, 245 (01) :1-11

[17] Macrophage liver x receptor is required for antiatherogenic activity of LXR agonists [J].

Levin, N ;

Bischoff, ED ;

Daige, CL ;

Thomas, D ;

Vu, CT ;

Heyman, RA ;

Tangirala, RK ;

Schulman, IG .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (01) :135-142

[18] Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis [J].

Lund, EG ;

Menke, JG ;

Sparrow, CP .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (07) :1169-1177

[19] Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers [J].

Repa, JJ ;

Turley, SD ;

Lobaccaro, JMA ;

Medina, J ;

Li, L ;

Lustig, K ;

Shan, B ;

Heyman, RA ;

Dietschy, JM ;

Mangelsdorf, DJ .

SCIENCE, 2000, 289 (5484) :1524-1529

[20] Role of LXRs in control of lipogenesis [J].

Schultz, JR ;

Tu, H ;

Luk, A ;

Repa, JJ ;

Medina, JC ;

Li, LP ;

Schwendner, S ;

Wang, S ;

Thoolen, M ;

Mangelsdorf, DJ ;

Lustig, KD ;

Shan, B .

GENES & DEVELOPMENT, 2000, 14 (22) :2831-2838

← 1 2 3 →